News
Biocon eyes weight-loss market in Canada, to file for generic Wegovy, Ozempic’s regulatory approvals
The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today. Oral GLP-1 pills, such as ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
From 1 July, the weight-loss drug Wegovy will become available from Belgian pharmacists on prescription. This means Wegovy is ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results